Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Harnesses, Slings, Carts, and Mobility Aids in Cancer Care
A properly selected and fitted aid can support transfers or walking, while a poor fit can create pain, pressure injury, falls, or caregiver strain.
Read moreHome-Environment Adaptation for Weak or Painful Oncology Patients
Small environmental changes can reduce falls, painful effort, and caregiver lifting while preserving access to basic needs and social contact.
Read moreCancer-Related Fatigue and Activity Pacing
Activity pacing balances movement and rest around disease, anemia, treatment, pain, cardiopulmonary status, sleep, and what the patient values.
Read moreLimb Swelling and Lymphedema: Measurement and Gentle Management
New swelling after tumor, node surgery, radiation, thrombosis, infection, or immobility needs diagnosis before compression, massage, or exercise is attempted.
Read more
Veterinary Acupuncture in Cancer Support: Symptom-Focused Evidence Boundary
Acupuncture may be discussed as an adjunct for selected pain, nausea, mobility, or wellbeing goals, but veterinary oncology-specific clinical evidence is limited.
Read more
Treatment Goals, Time, Cost, and Contingency Planning
A useful oncology plan makes the intended goal, expected care burden, financial boundaries, decision checkpoints, and backup options explicit without treating cost or caregiver limits as a failure.
Read moreVeterinary Cancer Clinical Trials: Eligibility, Consent, and Alternatives
A clinical trial may offer structured access to an investigational strategy or answer an important research question, but listing, enrollment, or novelty does not mean the study is…
Read more
Named profile Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence ProfileRepresentative category illustration – no product packaging is shown.Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence Profile
gilvetmab is covered as caninized anti-pd-1 monoclonal antibody immune-checkpoint inhibitor, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Oncept IL-2: Feline Fibrosarcoma Immunotherapy and EU Label ProfileRepresentative category illustration – no product packaging is shown.Oncept IL-2: Feline Fibrosarcoma Immunotherapy and EU Label Profile
feline interleukin-2 recombinant canarypox virus (vCP1338) is covered as veterinary biologic immunotherapy used with surgery and radiotherapy, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a…
Read more
Named profile Ifosfamide in Veterinary Oncology: Uroprotection and Organ-Safety ProfileRepresentative category illustration – no product packaging is shown.Ifosfamide in Veterinary Oncology: Uroprotection and Organ-Safety Profile
ifosfamide is covered as oxazaphosphorine alkylating agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Streptozotocin for Canine Insulinoma: Narrow-Indication Chemotherapy ProfileRepresentative category illustration – no product packaging is shown.Streptozotocin for Canine Insulinoma: Narrow-Indication Chemotherapy Profile
streptozotocin is covered as nitrosourea antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Dacarbazine in Veterinary Oncology: Infusion and Gastrointestinal-Risk ProfileRepresentative category illustration – no product packaging is shown.Dacarbazine in Veterinary Oncology: Infusion and Gastrointestinal-Risk Profile
dacarbazine is covered as triazene antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more